OPKO Health, Inc. Investment Warrants, Exercise Price
OPKO Health, Inc. (OPK) reported Investment Warrants, Exercise Price of $1.25 for the 1-month period ending 2011-08-31, per its 10-Q filed 2013-08-09.
Discontinued › Notes
invest:InvestmentWarrantsExercisePrice · last filed 2013-08-09
- 2011-08-31: Investment Warrants, Exercise Price 1 month $1.25.
| Period end | Investment Warrants, Exercise Price 1 month |
|---|---|
| 2011-08-31 | $1.25 10-Q · filed 2013-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |